NCT00280540View on ClinicalTrials.gov

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

648

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

August 31, 2006

Conditions
Hypertension
Interventions
DRUG

Valsartan/Hydrochlorothiazide

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY